Immune cell army plus drug shows promise against tough melanoma
Disease control
Ongoing
This early-stage trial tests a two-pronged attack on advanced melanoma. First, doctors remove some of the patient's own immune cells from a tumor, grow them into a larger army in a lab (Lifileucel), and put them back. Second, they give the drug pembrolizumab to help those cells w…
Phase: PHASE1 • Sponsor: Richard Wu • Aim: Disease control
Last updated May 12, 2026 13:42 UTC